TCR2 Therapeutics TCRR
$ 1.48
0.0%
Quarterly report 2023-Q1
added 05-11-2023
TCR2 Therapeutics Cash Flow 2011-2024 | TCRR
Annual Cash Flow TCR2 Therapeutics
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-101 M | -81.6 M | -56.7 M | -41.4 M | -18.7 M | - | - | - | - | - | - | - |
Depreciation & Amortization |
3.05 M | 2.83 M | 1.59 M | 862 K | 419 K | - | - | - | - | - | - | - |
Accounts Payables |
2.79 M | 2.14 M | 2.45 M | 2.48 M | - | - | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow TCR2 Therapeutics
2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-40 M | - | -76.5 M | -50.7 M | -31.1 M | - | -58.3 M | -38.9 M | -23.9 M | - | -43.2 M | -32.4 M | -16.4 M | - | -31 M | -21 M | -10.8 M | - | -12.3 M | -7.69 M | -3.01 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
615 K | - | 2.3 M | 1.41 M | 706 K | - | 1.98 M | 1.2 M | 513 K | - | 1.11 M | 673 K | 306 K | - | 558 K | 300 K | 135 K | - | 303 K | 188 K | 76 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
6.32 M | 2.79 M | 2.96 M | 5.47 M | 4.48 M | 2.14 M | 4.38 M | 4.82 M | 3.83 M | 2.45 M | 2.45 M | 2.45 M | 2.45 M | 2.48 M | 2.48 M | 2.48 M | 2.48 M | 2.66 M | 2.66 M | 2.66 M | 2.66 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency